Heikki Frick

508 total citations
9 papers, 421 citations indexed

About

Heikki Frick is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Heikki Frick has authored 9 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Heikki Frick's work include Cardiac Arrhythmias and Treatments (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Cardiovascular Syncope and Autonomic Disorders (2 papers). Heikki Frick is often cited by papers focused on Cardiac Arrhythmias and Treatments (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Cardiovascular Syncope and Autonomic Disorders (2 papers). Heikki Frick collaborates with scholars based in Finland, United States and Czechia. Heikki Frick's co-authors include Vesa Manninen, Matti Mänttäri, Pekka Koskinen, Leena Tenkanen, Heinonen Op, R Balcon, E Sowton, David F. Cross, J Hakkila and Pentti I. Halonen and has published in prestigious journals such as Circulation, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Heikki Frick

9 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heikki Frick Finland	7	215	214	154	59	56	9	421
H. Zeller Germany	4	299 1.4×	197 0.9×	112 0.7×	66 1.1×	79 1.4×	6	488
Castelli Wp United States	5	233 1.1×	225 1.1×	97 0.6×	82 1.4×	49 0.9×	9	487
Harrison Simpson Australia	7	343 1.6×	195 0.9×	214 1.4×	78 1.3×	91 1.6×	7	538
Gerald Klose Germany	13	218 1.0×	222 1.0×	130 0.8×	44 0.7×	94 1.7×	43	547
Anders Hamsten Sweden	7	225 1.0×	204 1.0×	144 0.9×	70 1.2×	128 2.3×	8	479
A. S. Krolewski United States	7	332 1.5×	163 0.8×	120 0.8×	25 0.4×	56 1.0×	14	507
B.J. Brenninkmeijer Netherlands	5	154 0.7×	140 0.7×	71 0.5×	44 0.7×	46 0.8×	6	254
V Schliack Germany	8	313 1.5×	116 0.5×	118 0.8×	26 0.4×	73 1.3×	18	470
J Patsch Austria	9	160 0.7×	170 0.8×	82 0.5×	58 1.0×	117 2.1×	15	420
Niina Mero Finland	7	338 1.6×	145 0.7×	185 1.2×	55 0.9×	125 2.2×	7	464

Countries citing papers authored by Heikki Frick

Since Specialization

Citations

This map shows the geographic impact of Heikki Frick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heikki Frick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heikki Frick more than expected).

Fields of papers citing papers by Heikki Frick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heikki Frick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heikki Frick. The network helps show where Heikki Frick may publish in the future.

Co-authorship network of co-authors of Heikki Frick

This figure shows the co-authorship network connecting the top 25 collaborators of Heikki Frick. A scholar is included among the top collaborators of Heikki Frick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heikki Frick. Heikki Frick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Manninen, Vesa, Leena Tenkanen, Pekka Koskinen, et al.. (1992). Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation. 85. 37–45. 312 indexed citations

Remme, Willem J., et al.. (1992). Pimobendan, a novel Ca2+-sensitizer/PDE-inhibitor, improves cardiac function without tolerance to its vasodilating effects during long-term therapy in moderate CHF. Journal of Molecular and Cellular Cardiology. 24. S72–S72. 1 indexed citations

Aalto‐Setälä, Katriina, Kimmo Kontula, Matti Mänttäri, et al.. (1991). DNA polymorphisms of apolipoprotein B and AI/CIII genes and response to gemfibrozil treatment. Clinical Pharmacology & Therapeutics. 50(2). 208–214. 13 indexed citations

Manninen, Vesa, et al.. (1990). Predictive value for coronary heart disease of baseline high-density and low-density lipoprotein cholesterol among Fredrickson type IIa subjects in the Helsinki Heart Study. The American Journal of Cardiology. 66(6). A24–A27. 10 indexed citations

Toivonen, Lauri, Markku S. Nieminen, Vesa Manninen, & Heikki Frick. (1987). Pirmenol in the termination of paroxysmal supraventricular tachycardia. The American Journal of Cardiology. 59(16). H35–H38. 8 indexed citations

Toivonen, Lauri, Markku S. Nieminen, Vesa Manninen, & Heikki Frick. (1987). Conversion of paroxysmal atrial fibrillation to Sinus rhythm by intravenous pirmenol. The American Journal of Cardiology. 59(16). H39–H42. 8 indexed citations

Nieminen, Markku S., Lauri Toivonen, Vesa Manninen, & Heikki Frick. (1987). Hemodynamic effects of pirmenol and lidocaine: A placebo-controlled, double-blind, comparative study. The American Journal of Cardiology. 59(16). H27–H32. 3 indexed citations

Sowton, E, R Balcon, David F. Cross, & Heikki Frick. (1968). Haemodynamic effects of I.C.I. 50172 in patients with ischaemic heart disease.. BMJ. 1(5586). 215–216. 41 indexed citations

Hakkila, J, Heikki Frick, & Pentti I. Halonen. (1958). Pericarditis and myocarditis caused by toxoplasma: Report of a case and review of the literature. American Heart Journal. 55(5). 758–765. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact